Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.
Lidington E, Hogan H, Gandolfi A, Lawrence J, Younger E, Cho H, Peckitt C, Mohammed K, Matharu S, Scerri L, Husson O, Cruickshank S, Turner R, Wedlake L. Lidington E, et al. Among authors: mohammed k. J Patient Rep Outcomes. 2022 Dec 22;6(1):128. doi: 10.1186/s41687-022-00529-9. J Patient Rep Outcomes. 2022. PMID: 36547735 Free PMC article.
Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.
Wedlake L, Shaw C, McNair H, Lalji A, Mohammed K, Klopper T, Allan L, Tait D, Hawkins M, Somaiah N, Lalondrelle S, Taylor A, VanAs N, Stewart A, Essapen S, Gage H, Whelan K, Andreyev HJN. Wedlake L, et al. Among authors: mohammed k. Am J Clin Nutr. 2017 Sep;106(3):849-857. doi: 10.3945/ajcn.116.150565. Epub 2017 Jul 5. Am J Clin Nutr. 2017. PMID: 28679552 Free article. Clinical Trial.
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Dillon MT, Boylan Z, Smith D, Guevara J, Mohammed K, Peckitt C, Saunders M, Banerji U, Clack G, Smith SA, Spicer JF, Forster MD, Harrington KJ. Dillon MT, et al. Among authors: mohammed k. Clin Transl Radiat Oncol. 2018 Jun 8;12:16-20. doi: 10.1016/j.ctro.2018.06.001. eCollection 2018 Aug. Clin Transl Radiat Oncol. 2018. PMID: 30073210 Free PMC article.
The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.
Andreyev HJN, Lalji A, Mohammed K, Muls ACG, Watkins D, Rao S, Starling N, Chau I, Cruse S, Pitkaaho V, Matthews J, Caley L, Pittordou V, Adams C, Wedlake L. Andreyev HJN, et al. Among authors: mohammed k. Support Care Cancer. 2021 Mar;29(3):1443-1453. doi: 10.1007/s00520-020-05610-x. Epub 2020 Jul 16. Support Care Cancer. 2021. PMID: 32676853 Free PMC article.
Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital.
Cunningham N, Shepherd S, Mohammed K, Lee KA, Allen M, Johnston S, Kipps E, McGrath S, Noble J, Parton M, Ring A, Turner NC, Okines AFC. Cunningham N, et al. Among authors: mohammed k. Breast Cancer Res Treat. 2022 Oct;195(3):333-340. doi: 10.1007/s10549-022-06703-3. Epub 2022 Aug 17. Breast Cancer Res Treat. 2022. PMID: 35976513 Free PMC article.
601 results